Promoter methylation detection of ALX4 has shown a sensitivity and specificity of 68% and 88% in CRC distinguish, respectively, and can be used as a molecular marker for early screening of colorectal cancer.31 This evidence concerns the gene ALX4 and colorectal carcinoma.